Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GHRS GH Research PLC | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $23.84 -2.5% | $14.86 -2.5% |
| StockIQ Score | 44D Weak Risk: Medium | 36F Weak Risk: Medium |
| Technical | 23F | 13F |
| Fundamental | 50C- | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 55C | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
GH Research PLC scores higher in stability and fundamentals, with an investor score of 47 versus AAPG’s 37 and a fundamental score of 50 compared to 35. However, AAPG leads in growth potential, with a growth score of 50 against GHRS’s 32. Both share the same valuation score of 38, but AAPG’s technical score of 18 is notably weaker than GHRS’s 34.
